Jiangsu Bioperfectus (China) Performance
| 688399 Stock | 74.74 1.26 1.66% |
The company retains a Market Volatility (i.e., Beta) of -0.51, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Jiangsu Bioperfectus are expected to decrease at a much lower rate. During the bear market, Jiangsu Bioperfectus is likely to outperform the market. Jiangsu Bioperfectus right now retains a risk of 3.02%. Please check out Jiangsu Bioperfectus mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to decide if Jiangsu Bioperfectus will be following its current trending patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Weak
Over the last 90 days Jiangsu Bioperfectus Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Jiangsu Bioperfectus is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Ex Dividend Date 2022-05-30 |
| Begin Period Cash Flow | 1.2 B |
Jiangsu |
Jiangsu Bioperfectus Relative Risk vs. Return Landscape
If you would invest 7,617 in Jiangsu Bioperfectus Technologies on August 27, 2024 and sell it today you would lose (143.00) from holding Jiangsu Bioperfectus Technologies or give up 1.88% of portfolio value over 90 days. Jiangsu Bioperfectus Technologies is generating 0.0124% of daily returns and assumes 3.0249% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Jiangsu, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Jiangsu Bioperfectus Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jiangsu Bioperfectus' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Jiangsu Bioperfectus Technologies, and traders can use it to determine the average amount a Jiangsu Bioperfectus' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0041
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 688399 |
Estimated Market Risk
| 3.02 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Jiangsu Bioperfectus is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jiangsu Bioperfectus by adding Jiangsu Bioperfectus to a well-diversified portfolio.
Jiangsu Bioperfectus Fundamentals Growth
Jiangsu Stock prices reflect investors' perceptions of the future prospects and financial health of Jiangsu Bioperfectus, and Jiangsu Bioperfectus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Jiangsu Stock performance.
| Return On Equity | -0.0496 | ||||
| Return On Asset | -0.0315 | ||||
| Profit Margin | (0.43) % | ||||
| Operating Margin | 0.32 % | ||||
| Current Valuation | 2.56 B | ||||
| Shares Outstanding | 56.67 M | ||||
| Price To Book | 1.31 X | ||||
| Price To Sales | 10.85 X | ||||
| Revenue | 403.18 M | ||||
| Gross Profit | 3.35 B | ||||
| EBITDA | (149.31 M) | ||||
| Net Income | (384.39 M) | ||||
| Total Debt | 164.76 M | ||||
| Book Value Per Share | 57.97 X | ||||
| Cash Flow From Operations | (113.14 M) | ||||
| Earnings Per Share | (2.92) X | ||||
| Total Asset | 3.91 B | ||||
| Retained Earnings | 2.51 B | ||||
About Jiangsu Bioperfectus Performance
By analyzing Jiangsu Bioperfectus' fundamental ratios, stakeholders can gain valuable insights into Jiangsu Bioperfectus' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Jiangsu Bioperfectus has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Jiangsu Bioperfectus has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Jiangsu Bioperfectus is entity of China. It is traded as Stock on SHG exchange.Things to note about Jiangsu Bioperfectus performance evaluation
Checking the ongoing alerts about Jiangsu Bioperfectus for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Jiangsu Bioperfectus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Jiangsu Bioperfectus had very high historical volatility over the last 90 days | |
| The company reported the revenue of 403.18 M. Net Loss for the year was (384.39 M) with profit before overhead, payroll, taxes, and interest of 3.35 B. | |
| Jiangsu Bioperfectus generates negative cash flow from operations | |
| About 49.0% of the company shares are owned by insiders or employees |
- Analyzing Jiangsu Bioperfectus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Jiangsu Bioperfectus' stock is overvalued or undervalued compared to its peers.
- Examining Jiangsu Bioperfectus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Jiangsu Bioperfectus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Jiangsu Bioperfectus' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Jiangsu Bioperfectus' stock. These opinions can provide insight into Jiangsu Bioperfectus' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Jiangsu Stock analysis
When running Jiangsu Bioperfectus' price analysis, check to measure Jiangsu Bioperfectus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jiangsu Bioperfectus is operating at the current time. Most of Jiangsu Bioperfectus' value examination focuses on studying past and present price action to predict the probability of Jiangsu Bioperfectus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jiangsu Bioperfectus' price. Additionally, you may evaluate how the addition of Jiangsu Bioperfectus to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |